Met Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Met Antibodies for advanced research in cell signaling and cancer biology. Met Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Met protein, also known as hepatocyte growth factor receptor (HGFR), plays a crucial role in cellular processes such as proliferation, survival, and migration. Met dysregulation is often implicated in various cancers, making it a significant target for therapeutic intervention and biomarker discovery. Understanding Met protein function and regulation is essential for developing strategies to combat cancer and other diseases associated with aberrant signaling. Met monoclonal antibodies enable detailed investigation of signaling mechanisms and molecular interactions in both normal and pathological conditions. Researchers can utilize Met monoclonal antibodies to examine expression patterns across different tissue types and cellular compartments. Met monoclonal antibodies support cutting-edge cancer research through precise detection and quantification methods. Santa Cruz Biotechnology monoclonal antibodies for Met continue to advance scientific understanding of cancer biology and potential therapeutic approaches.